BWX Technologies

BWX Technologies EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of BWX Technologies (BWXT) as of Nov 3, 2026 is 363.56 M USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 380.61 M USD — a change of -4.48% (lower).

EBITDA

363.56 MUSD

YoY

-4.48%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of BWX Technologies is 2025 363.56 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of BWX Technologies was 2024 380.61 M USD. It decreases by -4.48% lower compared to the previous year.

The BWX Technologies EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
304.98 M USD
Jan 1, 2019
325.52 M USD
Jan 1, 2020
389.05 M USD
Jan 1, 2021
381.19 M USD
Jan 1, 2022
348.57 M USD
Jan 1, 2023
383.06 M USD
Jan 1, 2024
380.61 M USD
Jan 1, 2025
363.56 M USD
The BWX Technologies EBITDA history
YEAREBITDAYoY
363.56 MUSD-4.48%
380.61 MUSD-0.64%
383.06 MUSD+9.89%
348.57 MUSD-8.56%
381.19 MUSD-2.02%
389.05 MUSD+19.52%
325.52 MUSD+6.74%
304.98 MUSD-1.83%
310.66 MUSD+28.28%
242.17 MUSD+17.59%
205.94 MUSD+719.67%
25.13 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

BWX Technologies Stock analysis

What does BWX Technologies do? BWX Technologies Inc. (BWXT) is a US-based company specializing in the manufacturing of nuclear energy products and services. The company has a long history dating back to 1867 when the Babcock & Wilcox Company (B&W) was founded. BWXT operates in three main areas: nuclear technology, government and environmental solutions, and nuclear medicine. Their nuclear technology division focuses on the development and production of reactor components, fuels, control rod systems, and supporting products and services. They also provide specialized services in relation to decommissioning nuclear power plants and radioactive waste disposal as part of their government and environmental solutions segment. In the field of nuclear medicine, BWXT focuses on the development and production of medical isotopes for cancer diagnosis and treatment. The company emphasizes stringent safety standards and collaborates closely with other organizations to ensure the safety and reliability of nuclear energy facilities. BWXT caters to both domestic and international customers and has production facilities in Canada, the UK, and China. Overall, BWXT is a leading player in the nuclear energy industry and continues to play a significant role through its diverse range of products and services. BWX Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BWX Technologies stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of BWX Technologies is 363.56 M USD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of BWX Technologies changed from 380.61 M USD to 363.56 M USD, representing a -4.48% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) BWX Technologies since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s BWX Technologies historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — BWX Technologies

All Key Metrics — BWX Technologies